REFERENCES
- Clark A. S., West K., Streicher S., Dennis P. A. Constitutive and Inducible Akt Activity Promotes Resistance to Chemotherapy, Trastuzumab, or Tamoxifen in Breast Cancer Cells. Mol. Cancer. Ther. 2002; 1: 707–717
- Campbell R. A., Bhat-Nakshatri P., Patel N. M., Constantinidou D., Ali S., Nakshatri H. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J. Biol. Chem. 2001; 276: 9817–9824
- deGraffenried L. A., Friedrichs W. E., Fulcher L., Fernandes G., Silva J. M., Peralba J.-M., Hidalgo M. Eicosapentaenoic Acid Restores Tamoxifen Sensitivity in Breast Cancer Cells with High Akt Activity. Ann Oncol. 2003; 14: 1051–1056
- Nicholson K. M., Anderson N. G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal, 2002; 14: 381–395
- Guo S., Rena G., Cichy S., He X., Cohen P., Unterman T. Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem. 1999; 274: 17184–17192
- Tang E. D., Nunez G., Barr F. G., Guan K.-L. Negative Regulation of the Forkhead Transcription Factor FKHR by Akt. J. Biol. Chem. 1999; 274: 16741–16746
- Medema R. H., Kops G. J., Bos J. L., Burgering B. M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature, 2000; 404: 782–787
- Burgering B. M.T., Kops G. J.P.L. Cell cycle and death control: long live Forkheads. Trends in Biochemical Sciences 2002; 27: 352–360
- Jackson J. G., Kreisberg J. I., Koterba A. P., Yee D., Brattain M. G. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Oncogene, 2000; 19: 4574–4581
- Rena G., Prescott A. R., Guo S., Cohen P., Unterman T. G. Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting. Biochem, J. 2001; 354: 605–612
- Mazumdar A., Kumar R. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells. FEBS Letters, 2003; 535: 6–10
- DeGraffenried L. A., Friedrichs W. E., Fulcher L., Fernandes G., Silva J. M., Peralba J. M., Hidalgo M. Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann Oncol. 2003; 14: 1051–1056